Don't close this page .. Test is protected .. Answers cannot be changed .. We try now to connect to save and correct your answers.
Connection trial number:
If this message persists for long, please check your internet connection.
This test is monitored
Switching to another webpage or any other program is considered a cheating behavior and your test may be automatically terminated.
Okay
Important Notice
If you moved to the next question, you will not be able to come back to this question again.
Cancel
Move to next question
Final exam لمادة صيدلة سريرية ٢ ( الامتحان مشترك)
Student data
×
Student data
Student name: ***
Student number: ***
Class or section: ***
Test instructions
×
Test instructions
التعليمات المهمة بامتحان ١- تاكد من ان عدد الاسءلة هي 141 سؤال ٢- اقرا سؤال جيدا قبل الجواب وعدم تسرع ٣- زمن الامتحان : ساعتان
Page direction
×
Change page direction
Right to left
Left to right
Q1
Score: 0.35
A- the most biologic DMARDs
B- they block TNF, which is a cytokine involved in the infkammato process
C- all TNF alpha inhibitors they are different Indication
D- Adalimumab is treat of Anti- TNF drug
Q2
Score: 0.35
A- NSAID+ PPI
B- NSAID+ prostaglandin analog
C- NSAID+ ASPIRIN
D- NSAID+ full dose histamine H2 blockers daily
Q3
Score: 0.35
A- methotrexate is a JAK inhibitors for use in patients with moderate to severe RA
B- adverse effects of JAK inhibitors they are similar to other biologic agents
C- is the targeted synthetic DMARDs
D- results in modulation and suppression of the immune system through cytokines signal reduction
Q4
Score: 0.35
صح
خطأ
Q5
Score: 0.35
صح
خطأ
Q6
Score: 0.35
A- meditation
B- psychotherapy
C- short term counseling
D- exercise
E- psycho- education
Q7
Score: 0.35
A- Bupropion
B- Venlafaxine
C- Aspirin
D- flecainide
Q8
Score: 0.35
A- uses age of onset : 35- 50 years
B- joint pattern is symmetric
C- ESR is normal
D- speed of onset is rapid
Q9
Score: 0.35
A- dosing of Infliximab is given by IV infusions
B- Etanercept is should be laboratory monitoring is required
C- MOA of Adlimumab is a chimeric antibody combining portions of mouse
D- certolizumab is FDA approved for use in JIA
Q10
Score: 0.35
A- the life time prevalence of anxiety disorder among American adult is 50%
B- SAD is the most common anxiety disorder
C- the female - to male ratio for any life time anxiety disorder is 1:2
D- all the above
Q11
Score: 0.35
A- EST
B- myths
C- light therapy
D- exercise
Q12
Score: 0.35
صح
خطأ
Q13
Score: 0.35
A- because adverse effect includes gastropathy
B- low therapeutic index
C- mucous membranes of the respitory trat
D- non the above
Q14
Score: 0.35
A- dry mouth is symptoms of PD
B- PET scan are used to visualize dopamine uptake in the substantia nigra and basal ganglia
C- the goal in the management of IPD is to improve motor and non motor symptoms
D- lifestyle modification is treatment of non pharmacologic therapy by PD
Q15
Score: 0.35
A- is symptomatic therapy of motor symptoms in early PD
B- side effect is tremor
C- they usually avoided or used with caution in patient > 70 years because of an increase risk of cognitive impairment
D- they decrease gastric motility
Q16
Score: 0.35
A- selective
B- non selective
C- all the above
Q17
Score: 0.35
صح
خطأ
Q18
Score: 0.35
A- adding lithium
B- adding folate
C- adding omega - 3 fatty acids
D- adding an anticonvulsant
Q19
Score: 0.35
A- Allopurinol and febuxostat are decrease serum uric acid
B- is increase uric acid excretion
C- is included drug : sulfinpyrazone
D- most patient with symptomatic hyperuricemia
Q20
Score: 0.35
A- alkalinization of urine : urine PH should be maintained at 6- 6.5
B- Losartan: DM given 100 mg / dl can be uricosuric
C- Febuxostat: it is a potential alternative to allpurinol for patients with gout
D- celecoxib is COX- 2 selective inhibitor
Q21
Score: 0.35
صح
خطأ
Q22
Score: 0.35
A- dry mouth
B- sedation
C- constipation.
D- all the above
E- non the above
Q23
Score: 0.35
A- given orally vit c
B- orally + SC
C- IV
Q24
Score: 0.35
A- probenecid
B- sulfinpyrazone
C- pegloticase
D- febuxostat
Q25
Score: 0.35
A- is recommended for patient with treatment resistant depression
B- is well tolerated , with minor visual complaints being the most frequently reported event
C- a non - invasive procedure to help fight depression
D- stimulation through a flexible
Q26
Score: 0.35
A- Naproxen+ PPI
B- can't NSAID
C- Increase NSAIDS
D- avoid NSAIDS if possible
Q27
Score: 0.35
صح
خطأ
Q28
Score: 0.35
صح
خطأ
Q29
Score: 0.35
A- the objective in treat OA is reduce pain
B- pharmacologic therapy is integral to achieving optimal outcomes
C- OA is primarily diagnosed on the clinical presentation
D- OA prevalence increased with age
Q30
Score: 0.35
A- emotional symptoms
B- intellectual or cognitive symptoms
C- physical symptoms
D- non the above
Q31
Score: 0.35
A- APhA
B- GAD
C- PD
D- SAD
Q32
Score: 0.35
صح
خطأ
Q33
Score: 0.35
A- is the second line
B- all benzodiazepine are equally effective anxiolytics.
C- is the first line
D- effect on GABA
Q34
Score: 0.35
A- T- cell
B- B- cell
C- IL-6
D- IL-1
E- JAK inhibitor
Q35
Score: 0.35
A- selective
B- non selective
C- both
Q36
Score: 0.35
A- muscle tone
B- tests
C- maintaining posture
D- regulating voluntary smooth motor activity
Q37
Score: 0.35
صح
خطأ
Q38
Score: 0.35
A- inhibitory properties at serotonin / norepinephrine reuptake transport
B- has potent antihistaminergic effect
C- antagonist at presynaptically a2- auto receptors and heteroreceptor , as well as post synaptic 5 HT2 and 5 HT3 receptor
D- the most common SE s are sedation and weight gain
Q39
Score: 0.35
A- target
B- biological
C- conventional
D- non the above
Q40
Score: 0.35
A- male gender
B- obesity
C- metabolic syndrome
D- temperature
Q41
Score: 0.35
صح
خطأ
Q42
Score: 0.35
A- The class of RA of NSAIDS is disease modifying therapy
B- aspirin is the prototype of traditional NSAIDS
C- corticosteroids they have bad anti- inflammatory
D- methotrexate is used symptomatic relief
Q43
Score: 0.35
صح
خطأ
Q44
Score: 0.35
A- NSAIDS
B- ASPIRIN
C- MONOAMINE - OXIDASE B INHIBITOR
D- WARFARIN
Q45
Score: 0.35
A- vasodilution
B- vasoconstriction
Q46
Score: 0.35
A- specific
B- non specific
C- both
Q47
Score: 0.35
A- Mirtazapine
B- Fluoxetine
C- paroxetine
D- Amitriptyline
E- vortioxetine
Q48
Score: 0.35
A- Mirtazapine
B- lithium
C- aspirin
D- A typical drug
Q49
Score: 0.35
صح
خطأ
Q50
Score: 0.35
A- SSRIs
B- TCA
C- SNRI
D- SS
Q51
Score: 0.35
A- phenelzine
B- paroxetine
C- Amitriptyline
D- clomipramine
Q52
Score: 0.35
A- skin
B- heart
C- all the above
Q53
Score: 0.35
A- most HA are injected once weekly for either 3 or 5 weeks
B- dose of Glucosamine sulfate: 10 mg
C- works of chondroitin are blocking the enzymes that break down old cartilage
D- Glucosamine and chondroitin are the most common
Q54
Score: 0.35
صح
خطأ
Q55
Score: 0.35
A- sertraline
B- paroxetine
C- citalopram
D- Doxepin
Q56
Score: 0.35
A- advanced age
B- gender
C- all the above
D- non the above
Q57
Score: 0.35
A- steroid
B- high protein intake
C- hyperthyroidism
D- all the above
E- non the above
Q58
Score: 0.35
A- definitive diagnosis
B- is diagnosis of joint fluid may also have an elevated WBC count with neutrophils predominating
C- the diagnosis of acute gouty arthritis may be made on the basis of presence of signs and symptoms
D- non the above
Q59
Score: 0.35
A- gender
B- bony remodeling
C- obesity
D- PIP
Q60
Score: 0.35
A- renal damage
B- renal calculi
C- clusters of urate generally surrounded by inflamed tissue
D- non the above
Q61
Score: 0.35
A- Acetaminophen should be administered initially on an as needed basis in daily doses up to 4 g
B- by single dose should exceed 1g
C- Acetaminophen should be tried initially at an adequate dose
D- Acetaminophen is effective for same indications as intermediate dose aspirin
Q62
Score: 0.35
A- is SNRIs
B- less D- D interaction than with SSRIs
C- is NDRI
D- the most common SEs are sedation and weight gain
Q63
Score: 0.35
A- anti acid decrease effect
B- protein decrease effect
C- increase beta 2 breakdowns of levadopa so decrease effect
D- all the above
Q64
Score: 0.35
A- panic disorder
B- generalized anxiety disorder
C- specific phobia
D- Posttraumatic stress disorder
Q65
Score: 0.35
A- monoarticular arthritis
B- just urate level rise in the blood without signs and symptoms
C- most patients have a second attack from 6 months to 2 years
D- complications include soft tissue damage
Q66
Score: 0.35
A- immediately
B- in addition
C- all the above
D- non the above
Q67
Score: 0.35
A- GABA
B- 5- HT2a
C- 4 - HT
D- b- blocker
Q68
Score: 0.35
A- Venlafaxine
B- Trazodone
C- Doxepin
D- Fluoxetine
E- paroxetine
Q69
Score: 0.35
A- ethanol
B- loop diuretics
C- cytotoxic drugs
D- nicotinic acid
Q70
Score: 0.35
A- high rate of diarrhea
B- prolong QT interval so consider other medication
C- helps sleep
D- longer half life compared to rest of SSRI
Q71
Score: 0.35
A- SAD can present in children of preschool to elementary school age
B- beta blocker : for not specific SAD only
C- TCA are not effective in SAD
D- beta blocker : a test dose at home
Q72
Score: 0.35
A- the crystal shape of gout: rhomboidal
B- joint involve of gout: large
C- pyrophosphate arthropathy also known as calcium pyrophosphate deposition disease
D- prevalence of gout is 0.4%, mf = 3.2 : 60- 80 year of age
Q73
Score: 0.35
A- heart
B- liver
C- joint
D- kidney
Q74
Score: 0.35
صح
خطأ
Q75
Score: 0.35
صح
خطأ
Q76
Score: 0.35
A- fewer side- effect
B- safety in over dose
C- high dosage titration
D- A+ B
E- B+ C
F- all the above
G- non the above
Q77
Score: 0.35
A- infection
B- lipid levels
C- all the above
D- non the above
Q78
Score: 0.35
A- most DMARDS require some form of monitoring to ensure safe therapy
B- NSAIDS and Glucocorticoid is drug of choose by DMARDS
C- DMARDS have slow onset of action
D- they have a major role in managing of RA
Q79
Score: 0.35
A- IV
B- Inhaler
C- SC
D- all the above
Q80
Score: 0.35
A- is Indirect action dopamine agonists
B- Selegiline is available in an orally disintegrating tablet designed to avoid first pass metabolism
C- Bromocriptine is not commonly used
D- side effect of rasageline are primarily GI related
Q81
Score: 0.35
صح
خطأ
Q82
Score: 0.35
A- 12
B- 8
C- 10
D- 20
E- 25
Q83
Score: 0.35
A- SNRI and TCA
B- SSRIs and MAOIS
C- CYP and HMG reductases
D- non the above
Q84
Score: 0.35
A- delusions
B- weight gain
C- weight loss
D- hallucination
Q85
Score: 0.35
A- patients should be reminded that the optimal effect of antidepressant May not be evident for 4 to 6 weeks
B- Theoretical advantage of SSRIs : require more dosage titration than older agents
C- in practice many clinicians persist in rapidly higher doses over the first few weeks
D- all the above
Q86
Score: 0.35
A- diet
B- degradation of nucleic acid
C- purine base
D- non the above
E- all the above
Q87
Score: 0.35
A- suicide
B- ECT
C- VNS
D- TMS
Q88
Score: 0.35
A- colchine
B- corticosteroids
C- naproxen
D- ALL THE ABOVE
Q89
Score: 0.35
A- suffient fiber and protein
B- alpha - Tocopherol , Q10 - CO - enzyme
C- Vit E , C
D- all the above
Q90
Score: 0.35
صح
خطأ
Q91
Score: 0.35
A- phenelzine
B- Amitriptyline
C- citalopram
D- sertraline
E- Duloxetine
Q92
Score: 0.35
A- anti depression
B- herbals
C- anti convulsants
D- antibiotics
Q93
Score: 0.35
صح
خطأ
Q94
Score: 0.35
A- 30- 50%
B- 70- 90%
C- 10- 15%
D- 60- 80%
Q95
Score: 0.35
A- over production of uric acid
B- combined of the above two mechanism
C- under excretion of UA
D- non the above
Q96
Score: 0.35
A- patient age
B- cost
C- patient preference
D- all the above
Q97
Score: 0.35
A- for 6- 9 month
B- never add single new drug to therapy
C- give drug not intermittent
Q98
Score: 0.35
A- is metabolized by mono amine oxidase
B- an inert neutral amino acid with no known pharmacologic effect
C- including L- dopa
D- adverse effect is seizure
Q99
Score: 0.35
A- TCA
B- SNRI
C- SSRI
D- MOA
Q100
Score: 0.35
A- anxiety
B- depression
C- eye
D- otitis media
Q101
Score: 0.35
A- on regular diet
B- normal individual
C- over producers
D- under excretors of uric acid
Q102
Score: 0.35
A- tremor
B- Dyskinasea
C- bradykinesia
D- postural instability
Q103
Score: 0.35
صح
خطأ
Q104
Score: 0.35
A- 100 mg
B- 300 mg
C- 500 mg
D- 200 mg
Q105
Score: 0.35
A- fluxetine
B- hypothyroidsem
C- paroxetine
D- vanflaxine
Q106
Score: 0.35
A- SSRI
B- SNRI
C- TCA
D- FLX
Q107
Score: 0.35
صح
خطأ
Q108
Score: 0.35
A- hip
B- pruritus
C- phototoxicity
D- dermatitis
Q109
Score: 0.35
A- 5HT2C
B- 5HT3
C- 5HT1A
D- 5HT2A
E- 5HT2C
F- all the above
Q110
Score: 0.35
A- methotrexate , sulfasalazine , hydroxy chloroquine is triple therapy
B- TNF- alpha is type of symptomatic relief
C- Minocycline is a tetracycline antibiotic
D- gold compound : May be given as IM or Oral
Q111
Score: 0.35
A- ibuprofen
B- rofecoxib
C- diclofenac
D- all the above
E- non the above
Q112
Score: 0.35
A- pulmonary TB
B- TB menengitise
C- extra pulmonary
Q113
Score: 0.35
A- panic disorder
B- social phobia
C- specific phobia
D- generalized anxiety disorder
Q114
Score: 0.35
A- IBS
B- IPD
C- MPTP
D- PARK1
Q115
Score: 0.35
A- zolpidem
B- Diazepam
C- temazepam
D- Fluoxetine
Q116
Score: 0.35
A- milder
B- acute
C- more chronic
D- A+ B
E- A+ C
F- all the above
Q117
Score: 0.35
A- 5HT1A IS ANTAGONIST
B- vomiting is 5HT3
C- SARA HAS DRINK ALCOHOL HAS MEAN RISK OF SUICIDE
D- ALL THE ABOVE
Q118
Score: 0.35
A- class D
B- class B
C- class C
D- class A
Q119
Score: 0.35
A- Benzbromarone
B- probenecid
C- sulfinpyrazone
D- rasburicase
Q120
Score: 0.35
A- FLX
B- SNRI
C- TCA
D- SSRI
Q121
Score: 0.35
A- fluoxetine
B- sertraline
C- citalopram
D- all the above
Q122
Score: 0.35
A- first 3 hours
B- first 12 hours
C- first 24 hours
D- first 50 hours
Q123
Score: 0.35
A- is the central hub for sights and sounds
B- is the emotional core of the brain whose primary role is to trigger the fear response
C- to be conscious of what you are seeing and hearing
D- is you memory centere
Q124
Score: 0.35
صح
خطأ
Q125
Score: 0.35
صح
خطأ
Q126
Score: 0.35
صح
خطأ
Q127
Score: 0.35
صح
خطأ
Q128
Score: 0.35
A- sulphasalazine
B- leflunomide
C- methotrexate
D- hydroxy chloroquine
Q129
Score: 0.35
A- dose of methotrexate : 5 mg
B- is have no monitoring
C- it is symptomatic relief of choice in RA
D- side effect of methotrexate is dry mouth
Q130
Score: 0.35
A- 3: 1
B- 2:3
c- 4: 1
D- 2:1
Q131
Score: 0.35
A- CNC
B- vomiting
C- hyperglycemia
D- fluid retention
Q132
Score: 0.35
A- second- line therapy
B- is inflammation with OA
C- cox2 inhibitors selectively block cox- 1 and not cox-2 activity
D- non the above
Q133
Score: 0.35
A- pegloticase is used in severe
B- rasburicase is Uricostatic agent
C- losartan : increase both uric acid excretion and urine oh
D- fenofibrate is also uricosuric and may be appropriate in select dyslipidemia patients with gout
Q134
Score: 0.35
A- radiographic changes
B- laboratory tests
C- signs
Q135
Score: 0.35
A- is functional impairment
B- is remission , patient should be free of panic attacks
C- is minimal agoraphobic avoidance
D- all the above
Q136
Score: 0.35
A- congenital or development deformities
B- erratic new bone formaion
C- bony remodeling
D- development of osteophytes
Q137
Score: 0.35
A- 29C
B- 33C
C- 21C
D- 37C
Q138
Score: 0.35
A- maintain joint function
B- response to colchicine treatment may suggest t tthe diagnosis
C- achieve rapid
D- avoid treatment related adverse effects
Q139
Score: 0.35
A- Levodopa
B- agents of interest are creatine and isradipine
B- dopamine agonist
D- all the above
Q140
Score: 0.35
A- selective
B- non selective
C- all the above
Q141
Score: 0.35
A- microfractures
B- the earliest stage of OA
C- subchondral bone
D- progressive loss of joint space
Exclusive and Special Deals for Our Visitors Only
Shop the latest products at the best global prices
Shop Now on Amazon
* Opens in a new window (you won’t leave our site)
As an Amazon Associate I earn from qualifying purchases.
Questions you haven't answered yet:
Are you sure you want to end this test and send your answers?
All copy rights reserved
©
arab-exams.com
2014-2023
Dismiss this alert